Portfolio company
Curve Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops small molecule and cyclic peptide drugs for pharmaceutical partners and patients to treat cancer, immunology and inflammatory diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kymera Therapeutics
This biotechnology company develops small molecule medicines that degrade disease-causing proteins for patients with cancer and immune-inflammatory diseases.
Biotheryx
The company develops protein degrader medicines for patients with cancer and inflammatory diseases.
Tentarix Biotherapeutics, LP
This biotechnology company develops conditionally active multispecific biologics for pharmaceutical partners to treat oncology and autoimmune diseases.
CV6 Therapeutics (NI) Ltd
This biotechnology company develops small molecule drugs that enhance chemotherapy and treat inflammatory diseases for patients with cancer and rheumatoid arthritis.
STipe Therapeutics
The company develops drugs targeting protein-protein interactions within the STING pathway to treat cancer and autoimmune diseases for healthcare institutions and pharmaceutical firms.
KyDo Therapeutics
This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.
Curileum
The company develops novel therapies and small molecule drugs to restore gastrointestinal tissue health for patients with bowel cancer and inflammatory bowel disease.
Bright Peak Therapeutics
This biotechnology company develops engineered cytokine immunotherapies and immunoconjugates to treat patients with cancer and autoimmune diseases.
